| Stephen Tilles, MD | |
|
9725 3rd Ave Ne Ste 500, Seattle, WA 98115-2024 | |
| (206) 527-1200 | |
| (206) 527-2514 |
| Full Name | Stephen Tilles |
|---|---|
| Gender | Male |
| Speciality | Allergy & Immunology |
| Location | 9725 3rd Ave Ne Ste 500, Seattle, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417984956 | NPI | - | NPPES |
| 030004970 | Other | WA | RAIL ROAD MEDICARE |
| 030005045 | Other | WA | RAILROAD MEDICAL |
| 8174450 | Medicaid | WA | |
| 030005046 | Other | WA | RAILROAD MEDICARE |
| 2079TI | Other | WA | REGENCE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | MD00038961 (Washington) | Primary |
| Entity Name | The Association Of University Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023041159 PECOS PAC ID: 0446162697 Enrollment ID: O20031105000244 |
News Archive
Theragenics Corporation, a medical device company serving the surgical products and prostate cancer treatment markets, today announced that it has signed an agreement with Oncura, Inc. for the distribution of TheraSeed® palladium-103 brachytherapy seeds. Oncura is a unit of GE Healthcare. Under the terms of the agreement, Theragenics will be the exclusive palladium-103 seed supplier to Oncura, subject to certain pre-existing vendor agreements, for the treatment of prostate cancer in the U.S. and Canada.
Researchers from the Harvard School of Public Health and the American Cancer Society have found that regular use of vitamin E supplements may reduce the risk for death from amyotrophic lateral sclerosis (ALS) also known as Lou Gehrig's Disease.
The administration of infliximab after intestinal resective surgery was found to be effective at preventing endoscopic and histological recurrence of Crohn's disease, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.
Conquering the last frontier for monitoring vital signs, Brain Tunnelgenix Technologies Corp. is introducing the Abreu btt™ 700 System for continuous temperature monitoring at the Annual Meeting of the American Society of Anesthesiologists (ASA) today. The Abreu btt 700 System sensor is approved by the U.S. Food and Drug Administration for placement on the skin and to be used during surgical procedures, recovery room, intensive care and general patient monitoring.
› Verified 9 days ago
| Entity Name | Seattle Children's Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003319500 PECOS PAC ID: 9032021050 Enrollment ID: O20031211000532 |
News Archive
Theragenics Corporation, a medical device company serving the surgical products and prostate cancer treatment markets, today announced that it has signed an agreement with Oncura, Inc. for the distribution of TheraSeed® palladium-103 brachytherapy seeds. Oncura is a unit of GE Healthcare. Under the terms of the agreement, Theragenics will be the exclusive palladium-103 seed supplier to Oncura, subject to certain pre-existing vendor agreements, for the treatment of prostate cancer in the U.S. and Canada.
Researchers from the Harvard School of Public Health and the American Cancer Society have found that regular use of vitamin E supplements may reduce the risk for death from amyotrophic lateral sclerosis (ALS) also known as Lou Gehrig's Disease.
The administration of infliximab after intestinal resective surgery was found to be effective at preventing endoscopic and histological recurrence of Crohn's disease, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.
Conquering the last frontier for monitoring vital signs, Brain Tunnelgenix Technologies Corp. is introducing the Abreu btt™ 700 System for continuous temperature monitoring at the Annual Meeting of the American Society of Anesthesiologists (ASA) today. The Abreu btt 700 System sensor is approved by the U.S. Food and Drug Administration for placement on the skin and to be used during surgical procedures, recovery room, intensive care and general patient monitoring.
› Verified 9 days ago
| Entity Name | Northwest Asthma & Allergy Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760620462 PECOS PAC ID: 6507759743 Enrollment ID: O20040209000462 |
News Archive
Theragenics Corporation, a medical device company serving the surgical products and prostate cancer treatment markets, today announced that it has signed an agreement with Oncura, Inc. for the distribution of TheraSeed® palladium-103 brachytherapy seeds. Oncura is a unit of GE Healthcare. Under the terms of the agreement, Theragenics will be the exclusive palladium-103 seed supplier to Oncura, subject to certain pre-existing vendor agreements, for the treatment of prostate cancer in the U.S. and Canada.
Researchers from the Harvard School of Public Health and the American Cancer Society have found that regular use of vitamin E supplements may reduce the risk for death from amyotrophic lateral sclerosis (ALS) also known as Lou Gehrig's Disease.
The administration of infliximab after intestinal resective surgery was found to be effective at preventing endoscopic and histological recurrence of Crohn's disease, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.
Conquering the last frontier for monitoring vital signs, Brain Tunnelgenix Technologies Corp. is introducing the Abreu btt™ 700 System for continuous temperature monitoring at the Annual Meeting of the American Society of Anesthesiologists (ASA) today. The Abreu btt 700 System sensor is approved by the U.S. Food and Drug Administration for placement on the skin and to be used during surgical procedures, recovery room, intensive care and general patient monitoring.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephen Tilles, MD 9725 3rd Ave Ne Ste 500, Seattle, WA 98115-2024 Ph: (206) 527-1200 | Stephen Tilles, MD 9725 3rd Ave Ne Ste 500, Seattle, WA 98115-2024 Ph: (206) 527-1200 |
News Archive
Theragenics Corporation, a medical device company serving the surgical products and prostate cancer treatment markets, today announced that it has signed an agreement with Oncura, Inc. for the distribution of TheraSeed® palladium-103 brachytherapy seeds. Oncura is a unit of GE Healthcare. Under the terms of the agreement, Theragenics will be the exclusive palladium-103 seed supplier to Oncura, subject to certain pre-existing vendor agreements, for the treatment of prostate cancer in the U.S. and Canada.
Researchers from the Harvard School of Public Health and the American Cancer Society have found that regular use of vitamin E supplements may reduce the risk for death from amyotrophic lateral sclerosis (ALS) also known as Lou Gehrig's Disease.
The administration of infliximab after intestinal resective surgery was found to be effective at preventing endoscopic and histological recurrence of Crohn's disease, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.
Conquering the last frontier for monitoring vital signs, Brain Tunnelgenix Technologies Corp. is introducing the Abreu btt™ 700 System for continuous temperature monitoring at the Annual Meeting of the American Society of Anesthesiologists (ASA) today. The Abreu btt 700 System sensor is approved by the U.S. Food and Drug Administration for placement on the skin and to be used during surgical procedures, recovery room, intensive care and general patient monitoring.
› Verified 9 days ago
Dr. Daniel H Petroni, M.D., PH.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 9725 3rd Ave Ne, Suite 500, Seattle, WA 98115 Phone: 206-527-1200 Fax: 206-523-0724 | |
Sana Patel, Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 4500 40th Ave Ne, Seattle, WA 98105 Phone: 206-987-8811 | |
Susan S Xie, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 2671 Ne 46th St, Seattle, WA 98105 Phone: 206-525-8000 Fax: 206-525-8070 | |
Timothy J. Baltz, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 200 15th Ave E, Seattle, WA 98112 Phone: 206-326-3000 | |
Ashley M Jerath Tatum, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 9725 3rd Ave Ne Ste 500, Seattle, WA 98115 Phone: 206-527-1200 Fax: 206-527-2514 | |
John B. Yuen, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1101 Madison St, Suite 301, Seattle, WA 98104 Phone: 206-505-1104 | |
Frank S Virant, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 9725 3rd Ave Ne Ste 500, Seattle, WA 98115 Phone: 206-527-1200 Fax: 206-527-2514 |